The latest closing stock price for XTL Biopharmaceuticals as of July 18, 2025 is 1.76.
An investor who bought $1,000 worth of XTL Biopharmaceuticals stock at the IPO in 2005 would have $-997 today, roughly -1 times their original investment - a -25.11% compound annual growth rate over 20 years.
The all-time high XTL Biopharmaceuticals stock closing price was 571.00 on September 01, 2005.
The XTL Biopharmaceuticals 52-week high stock price is 3.05, which is 73.3% above the current share price.
The XTL Biopharmaceuticals 52-week low stock price is 0.86, which is 51.1% below the current share price.
The average XTL Biopharmaceuticals stock price for the last 52 weeks is 1.77.
An investor who bought $1,000 worth of XTL Biopharmaceuticals stock at the IPO in 2005 would have $-997 today, roughly -1 times their original investment - a -25.11% compound annual growth rate over 20 years.
The all-time high XTL Biopharmaceuticals stock closing price was 571.00 on September 01, 2005.
The XTL Biopharmaceuticals 52-week high stock price is 3.05, which is 73.3% above the current share price.
The XTL Biopharmaceuticals 52-week low stock price is 0.86, which is 51.1% below the current share price.
The average XTL Biopharmaceuticals stock price for the last 52 weeks is 1.77.